Evidence map›Paper›PMID 29085960›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2018

Transforming growth factor-β1 and phosphatases modulate COX-2 protein expression and TAU phosphorylation in cultured immortalized podocytes.

Maya S Abdallah, Christopher R J Kennedy, Joseph S Stephan, Pamela Abou Khalil, Mohammad Mroueh, Assaad A Eid, Wissam H Faour

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. PP2 Ameliorates Renal Fibrosis by Regulating the NF-Oxidative medicine and cellular longevity · 2021
    Article
  5. Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Maya S AbdallahInstitut Européen des Membranes, Université de Montpellier, Montpellier, France.
Christopher R J KennedyDivision of Nephrology, Department of Medicine, Kidney Research Centre, The Ottawa Hospital, Ottawa, ON, K1H 8M5, Canada.
Joseph S StephanGilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, PO Box 36, Byblos, Lebanon.
Pamela Abou KhalilGilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, PO Box 36, Byblos, Lebanon.
Mohammad MrouehSchool of Pharmacy, Lebanese American University, P.O. Box 36, Byblos, Lebanon.
Assaad A EidSchool of Medicine, American University of Beirut, Beirut, Lebanon.
Wissam H FaourGilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, PO Box 36, Byblos, Lebanon. wissam.faour@lau.edu.lb.ORCID http://orcid.org/0000-0002-0746-3687
Lebanese American University · LBAmerican University of Beirut · LBOttawa Hospital · CAUniversité de Montpellier · FR

Funding

National council for Scientific Research in Lebanon 01-08-15
6 · The paper itself

Abstract

OBJECTIVE AND

designThe aim of this study is to elucidate TGF-β1 signaling pathways involved in COX-2 protein induction and modulation of TAU protein phosphorylation in cultured podocytes. MATERIALS, TREATMENT AND

methodsIn vitro cultured immortalized podocytes were stimulated with TGF-β1 in presence and absence of pharmacologic inhibitors for various signaling pathways and phosphatases. Then, COX-2 protein expression, as well as P38MAPK, AKT and TAU phosphorylation levels were evaluated by western blot analysis.

resultsTGF-β1 induction of COX-2 protein levels was completely blocked by pharmacologic inhibitors of phosphatases, P38 MAPK, or NF-қB pathways. Time course experiments showed that TGF-β1 activated p38 MAPK after 5 min of stimulation. Interestingly, podocyte co-incubated with TGF-β1, high glucose and/or PGE2 showed strong increase in p38 MAPK and AKT phosphorylation as well as COX- 2 protein expression levels. Levels of phosphorylated AKT were further reduced and levels of phosphorylated p38 were increased when PGE2 was added to the culture media. Interestingly, selective phosphatases inhibitors completely abrogated PGE2-induced P38 MAPK and TAU phosphorylation. Also, inhibition of phosphatases reversed TGF-β1-induced COX-2 protein expression either alone or when incubated with high glucose or PGE2.

conclusionThese data suggest TGF-β1 mediates its effect in podocyte through novel signaling mechanisms including phosphatases and TAU protein phosphorylation.

Indexed as

AnimalsCells, CulturedCyclooxygenase 2GlucoseMiceNF-kappa Bp38 Mitogen-Activated Protein KinasesPhosphoric Monoester HydrolasesPhosphorylationPodocytesSignal Transductiontau ProteinsTransforming Growth Factor beta1Cyclooxygenase 2GlucoseNF-kappa Bp38 Mitogen-Activated Protein KinasesPhosphoric Monoester HydrolasesPTGS2 protein, humantau ProteinsTransforming Growth Factor beta1CyclooxygenaseDiabetic nephropathyPodocytesTAUTGF-β1

Identifiers

PMID29085960
OpenAlexW2766941487

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.